Rachel E. Haurwitz insider trades

Open-market stock purchases and sales by Rachel E. Haurwitz, President and CEO at Caribou Biosciences, Inc, from SEC Form 4 filings since May 5, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +88%.

Recent trades

DateStockTradeValue
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—

Companies traded

  • CRBU Caribou Biosciences, Inc: 1 buy, last Feb 20, 2026
  • SEER Seer, Inc: other filings, last Jun 12, 2024
  • NTLA Intellia Therapeutics, Inc: other filings, last May 11, 2016

Get free alerts when Rachel E. Haurwitz files a new trade →